EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Biological Characterization of Macromolecular Ester Prodrugs of a Selective Cyclooxygenase‐2 Inhibitor

Mario Saletti, Marco Paolino iD, Jacopo Venditti iD, Germano Giuliani iD, Antonietta Rossi iD, Danilo D'Avino iD, Sara Perna, Ina Varfaj iD, Roccaldo Sardella iD, Antonio Macchiarulo iD, Samuele Maramai iD, Stefania Lamponi und 2 weitere

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Mario Saletti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via Aldo Moro 2, 53100, Siena, Italy. Hauptthemen laut MEDLINE: Prodrugs, Cyclooxygenase 2 Inhibitors, Drug Design, Cyclooxygenase 2. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-Next Generation EU under the Italian Ministry of University and Research (MUR) National Innovation Ecosystem ECS00000041 - VITALITY - CUP, Italian Ministry of University and Research, University of Naples Federico II - Department of Pharmacy, "Progetto di Eccellenza 2022-2027".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Owing to the importance of tracing new routes in the development of macromolecular prodrugs, in the present work, two potential macromolecular ester prodrugs (i.e., 12a and 13a ) of selective cyclooxygenase‐2 (COX‐2) inhibitor 7b are designed and synthesized. In the design, two different oligo(ethylene glycol)‐based spacers are linked through a ferulate residue to the backbone hyaluronic acid ( HA ) showing a medium molar mass value (i.e., Mw = 270 kDa). The spacers are designed to differ in the sensitivity to the hydrolytic conditions so that the chemical hydrolysis of ferulate ester bond in 12a is assumed to produce the corresponding ferulic acid derivative 12b . On the other hand, the same reaction in 13a leading to ferulate derivative 13b could be accompanied by the hydrolysis of the second ester bond with the release of the selective COX‐2 inhibitor 7b . The COX inhibitory activity of the newly synthesized compounds is evaluated in vitro, and macromolecular ester prodrugs 12a and 13a are found to be completely inactive together with hydrolysis product 12b . Conversely, these in vitro studies reveal the intriguing COX‐2 inhibitory activity and selectivity of ferulate derivative 13b related to macromolecular ester prodrug 13a . Therefore, to obtain information on the hydrolysis process in different environments, hydrolysis studies are performed on macromolecular ester prodrug 13a by using 1 H NMR and UHPLC‐MS techniques. These studies show that severe hydrolytic conditions (i.e., aqueous NaOH solutions) promote the rapid release of potent and selective COX‐2 inhibitor 7b , whereas in ammonium acetate buffer the release is slower. Overall, these results lead to envision possible applications of the design approach to the development of macromolecular ester prodrugs of all the drug molecules bearing hydroxyl groups in their structures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsCyclooxygenase 2 InhibitorsDrug DesignCyclooxygenase 2EstersHumansMolecular StructureCoumaric AcidsStructure-Activity RelationshipMacromolecular SubstancesHydrolysis

Stichwörter der Autor:innen

COX‐2 inhibitorsanti‐inflammatory agentsferulic acidhyaluronic acidprodrugs

Substanzen

ProdrugsCyclooxygenase 2 InhibitorsCyclooxygenase 2EstersCoumaric AcidsMacromolecular Substances

Autor:innen und Institutionen

  • Dipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via Aldo Moro 2, 53100, Siena, Italy.
  • Dipartimento di Farmacia, Scuola di Medicina e Chirurgia, Università di Napoli "Federico II", Via D. Montesano 49, I-80131, Napoli, Italy.
  • Dipartimento di Scienze Farmaceutiche, Università di Perugia, Via Fabretti 48, 06123, Perugia, Italy.

ORCID-Profile: Marco Paolino, Jacopo Venditti, Germano Giuliani, Antonietta Rossi, Danilo D'Avino, Ina Varfaj, Roccaldo Sardella, Antonio Macchiarulo, Samuele Maramai, Andrea Cappelli, Maurizio Anzini

Förderung

  • European Union-Next Generation EU under the Italian Ministry of University and Research (MUR) National Innovation Ecosystem ECS00000041 - VITALITY - CUP
  • Italian Ministry of University and Research
  • University of Naples Federico II - Department of Pharmacy, "Progetto di Eccellenza 2022-2027"

Zitieren

APA

Saletti, M., Paolino, M., Venditti, J., Giuliani, G., Rossi, A., D'Avino, D., Perna, S., Varfaj, I., Sardella, R., Macchiarulo, A., Maramai, S., Lamponi, S., Cappelli, A., & Anzini, M. (2025). Design, Synthesis, and Biological Characterization of Macromolecular Ester Prodrugs of a Selective Cyclooxygenase‐2 Inhibitor. ChemMedChem. https://doi.org/10.1002/cmdc.202500691

Vancouver

Saletti M, Paolino M, Venditti J, Giuliani G, Rossi A, D'Avino D, et al. Design, Synthesis, and Biological Characterization of Macromolecular Ester Prodrugs of a Selective Cyclooxygenase‐2 Inhibitor. ChemMedChem. 2025. doi:10.1002/cmdc.202500691

BibTeX
@article{Saletti2025,
  author = {Saletti, Mario and Paolino, Marco and Venditti, Jacopo and Giuliani, Germano and Rossi, Antonietta and D'Avino, Danilo and Perna, Sara and Varfaj, Ina and Sardella, Roccaldo and Macchiarulo, Antonio and Maramai, Samuele and Lamponi, Stefania and Cappelli, Andrea and Anzini, Maurizio},
  title = {Design, Synthesis, and Biological Characterization of Macromolecular Ester Prodrugs of a Selective Cyclooxygenase‐2 Inhibitor},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500691}
}
Kostenlos starten →